Drugs / 444563
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01107587 | Apr → Jun 2010 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 444563 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01107587 ↗ |
| Modality | Vaccine | “Oral Live Attenuated Liquid Human Rotavirus (HRV) Vaccine 444563” NCT01107587 ↗ |
| Route | Oral | “Oral, two doses.” NCT01107587 ↗ |